Newsroom

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) to evaluate ivonescimab, a novel, potential first-in-class investigational bispecific antibody, in a registration-enabling Phase II/III study in biliary tract cancer (BTC). The new study, EA2251 (NCT07765433), is designed to evaluate the safety and efficacy of ivonescimab with chemotherapy compared to pembrolizumab or durvalumab pl...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 20.10.2026 FTMO.LN IE000CY30YV9 3,125,002.00 USD  94,375,647.35   30.200  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

SALT LAKE CITY--(BUSINESS WIRE)--Gilmore & Bell, P.C., a leading public finance law firm, is pleased to announce that Kiersten Davies has joined the firm as an associate in the Salt Lake City office. Ms. Davies received a B.S. in Finance from Brigham Young University in 2023. She received her J.D. (with high honors) from the University of Utah, S.J. Quinney College of Law in 2026. While in law school, Ms. Davies was a College of Law academic scholarship recipient and served as a Note and Co...

KANSAS CITY, Mo.--(BUSINESS WIRE)--Gilmore & Bell, P.C., a leading public finance law firm, is pleased to announce that Alberta Engelman has joined the firm as an associate in the Kansas City office. Ms. Engelman received a B.A. in Journalism with a focus on Broadcast Radio/TV and a Minor in English from the University of Missouri in 2021. She received her J.D. from the University of Missouri School of Law in 2026. During law school, Ms. Engelman served as an Associate Member of the Journal...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 20.10.2026 SDVI.LN IE000YVOQ2A3   40,361.00 USD   1,147,481.60   28.430  ...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that two oral presentations and two poster presentations featuring its NeXT Personal ultrasensitive circulating tumor DNA (ctDNA) test will be presented at the European Society for Medical Oncology (ESMO) Congress 2026, taking place October 23-27 in Madrid, Spain. Highlights include a late-breaking oral presentation of NeXT Personal data for the C-POST Phase 3...

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2026 results ahead of expectations. "Elevance Health's third quarter results reflect stronger execution across our diversified portfolio and underscore the earnings power of the business. We are raising our 2026 earnings outlook and remain confident in delivering at least 12% growth in adjusted diluted earnings per share in 2027 from our higher earnings baseline of at least $26.753. By bringing together the...

HOPKINS, S.C.--(BUSINESS WIRE)--Westinghouse Electric Company today announced an approximately $1 billion investment to construct one of the most advanced nuclear fuel factories in the United States at its Columbia Fuel Fabrication Facility in Hopkins, S.C. This plant, which is the first fleet-scale nuclear fuel factory built in the United States in more than 50 years, is expected to lead the way in commercial scale Low Enriched Uranium Plus (LEU+) fuel production. Construction on the new LEU+ F...